These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 17940127

  • 1. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 2. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
    Lee JJ, Lam MS, Rosenberg A.
    Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
    [Abstract] [Full Text] [Related]

  • 3. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 4. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorder.
    Kalinova L, Indrakova J, Bachleda P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec 15; 153(4):251-7. PubMed ID: 20208963
    [Abstract] [Full Text] [Related]

  • 6. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J, Einsele H, Gil L, Ljungman P.
    Transpl Infect Dis; 2009 Oct 15; 11(5):383-92. PubMed ID: 19558376
    [Abstract] [Full Text] [Related]

  • 7. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 8. Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
    Svoboda J, Kotloff R, Tsai DE.
    Transpl Int; 2006 Apr 15; 19(4):259-69. PubMed ID: 16573540
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 15; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 15; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 11. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar 15; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 12. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH, Morrison VA.
    Expert Rev Hematol; 2010 Feb 15; 3(1):35-44. PubMed ID: 21082932
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative diseases.
    Gross TG, Savoldo B, Punnett A.
    Pediatr Clin North Am; 2010 Apr 15; 57(2):481-503, table of contents. PubMed ID: 20371048
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 15. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 16. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 20; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 17. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 18. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
    Glotz D, Chapman JR, Dharnidharka VR, Hanto DW, Castro MC, Hirsch HH, Leblond V, Mehta AK, Moulin B, Pagliuca A, Pascual J, Rickinson AB, Russo FP, Trappe RU, Webster AC, Zuckermann AO, Gross TG.
    Transplantation; 2012 Oct 27; 94(8):784-93. PubMed ID: 22992767
    [Abstract] [Full Text] [Related]

  • 19. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU.
    Transplantation; 2012 Mar 15; 93(5):543-50. PubMed ID: 22234349
    [Abstract] [Full Text] [Related]

  • 20. Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder.
    Campisi P, Allen UD, Ngan BY, Hawkes M, Forte V.
    Otolaryngol Head Neck Surg; 2007 Aug 15; 137(2):296-300. PubMed ID: 17666259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.